Erisyon's new fluorosequencing technology will revolutionize the way we detect, treat, and track genetic diseases such as cancer, Parkinson's disease, and Alzheimer's - just to name a few of the big ones. By running billions of simultaneous digital experiments with uncompromised sensitivity using AI computing power, this new lab device will provide faster breakthroughs for researchers working on DNA sequencing. Herbst worked with Erisyon to create an intelligent brand that clearly communicates the science as well as the floor standing device design, worthy of the light speed technology within.
"Poised to have an outsized impact on science in the coming year." - Nature
Herbst defined a precise and intelligent brand language, complete with photography style, iconography, and a website execution. Our key word was enlightening, as it plays on Erisyon's proprietary light spectrum technology and the profound insights it will provide.
Herbst worked closely with Erisyon to learn the technology, synthesize complex scientific information, and story-board an animation to make the process of fluorosequencing accessible to people who want to learn more about this breakthrough genetic disease research.
Parkinson’s disease is a debilitating neurodegenerative disorder that affects an estimated 1 million sufferers in the United States alone. Beyond genetic diseases in the same category such as cancer and Alzheimer's, Erisyon's technology can be applied to animal viruses like Covid-19, plant breeding, and drug development.
